Metis Global Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.16M | Sell |
17,652
-5,841
| -25% | -$2.37M | 0.18% | 88 |
|
|
2025
Q1 | $11.7M | Buy |
23,493
+2,503
| +12% | +$1.25M | 0.33% | 46 |
|
|
2024
Q4 | $10.9M | Sell |
20,990
-316
| -1% | -$164K | 0.33% | 47 |
|
|
2024
Q3 | $13.2M | Buy |
21,306
+565
| +3% | +$349K | 0.41% | 42 |
|
|
2024
Q2 | $11.5M | Sell |
20,741
-78
| -0.4% | -$43.1K | 0.39% | 41 |
|
|
2024
Q1 | $12.1M | Sell |
20,819
-83
| -0.4% | -$48.2K | 0.44% | 39 |
|
|
2023
Q4 | $11.1M | Buy |
20,902
+2,828
| +16% | +$1.5M | 0.44% | 40 |
|
|
2023
Q3 | $9.15M | Buy |
18,074
+2,358
| +15% | +$1.19M | 0.44% | 36 |
|
|
2023
Q2 | $8.2M | Sell |
15,716
-90
| -0.6% | -$47K | 0.44% | 36 |
|
|
2023
Q1 | $9.11M | Buy |
15,806
+4,394
| +39% | +$2.53M | 0.58% | 28 |
|
|
2022
Q4 | $6.28M | Buy |
11,412
+4,145
| +57% | +$2.28M | 0.56% | 29 |
|
|
2022
Q3 | $3.69M | Buy |
7,267
+612
| +9% | +$310K | 0.59% | 28 |
|
|
2022
Q2 | $3.62M | Buy |
6,655
+437
| +7% | +$237K | 0.58% | 29 |
|
|
2022
Q1 | $3.67M | Buy |
6,218
+2,792
| +81% | +$1.65M | 0.44% | 32 |
|
|
2021
Q4 | $2.29M | Buy |
+3,426
| New | +$2.29M | 0.64% | 25 |
|